Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 1Recurrence 1Carcinoma, Small Cell 1

Interventions

Cisplatin 4Etoposide 2veliparib 1sagopilone 1sacituzumab govitecan 1pomalidomide 1pembrolizumab 1etoposide phosphate 1Topotecan 1Tomography, X-Ray Computed 1Temozolomide 1Rhenium 1Radiation 1Positron-Emission Tomography 1Podophyllotoxin 1Platinum 1Penfluridol 1Pemetrexed 1PT-100 dipeptide 1Histamine Antagonists 1Epinephrine 1Electrocardiography 1Diphenhydramine 1Dexamethasone 1Calcium Dobesilate 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Carcinoma, Small Cell × Penfluridol × Clear all
NCT07206563 2025-10-03

Penfluridol for Relapsed/Refractory Small Cell Cancers

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 1/2 Not yet recruiting
33 enrolled
Thoracic

Recurrence, Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡